A Comparison of Intravascular Penetration With Curved Needle and Straight Needle During S1 STE
NCT ID: NCT05956054
Last Updated: 2023-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2023-06-22
2024-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
• whether there is a difference in intravascular rate between using a straight needle and a curved needle in S1 transforaminal epidural injection
Participants in this study will be randomly assigned to receive an S1 transforaminal epidural injection using either a straight needle or a curved needle. The researchers will then observe the intravasation rate and compare it between the two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent or Straight Needles
NCT05849324
S1 Transforaminal Injection and Vascular Incidence
NCT04634955
Intravascular Injection Rates During Lumbar Medial Branch Block
NCT05020509
Intravascular Injection Incidences During Lumbar Medial Branch Block
NCT05362084
Ultrasound-assisted Thoracic Epidural Catheter Insertion
NCT03890640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
S1 transforaminal injection with a straight needle
needle type
straight or curved
S1 transforaminal injection with a curved needle
needle type
straight or curved
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
needle type
straight or curved
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients with a history of allergy to contrast media
3. Patients with a bleeding tendency
4. Patients with symptoms of infection in the sacroiliac region
5. Patients under 18 years of age or over 80 years of age
6. Patients who are pregnant or planning to become pregnant
7. Other medically incapable of consent, such as the mentally retarded.
Translated with www.DeepL.com/Translator (free version)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Chilgok Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jinyoung Oh
assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyungpook National University Hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jinyoung Oh, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-04-018-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.